In the last 12 months, insiders at ACCENDRA HEALTH INC/VA/ ($ACH) filed 117 transactions with the SEC: 12 open-market purchases totaling $42,850,670 and 19 sales totaling $2,365,588. Net insider sentiment: net buying.
ACCENDRA HEALTH INC/VA/ operates in the Wholesale-medical, dental & hospital equipment & supplies industry (Trade & services sector).
Most Active Insiders
- Coliseum Capital Management, LLC (Not found) — 12 transactions totaling $42,850,670
- Pesicka Edward A (President & CEO) — 8 transactions totaling $2,875,128
- Bernocchi Perry A (EVP, CEO,. Patient Direct) — 13 transactions totaling $1,882,432
- Long Andrew G (EVP, CEO P&HS) — 8 transactions totaling $1,290,574
- Leon Jonathan A (SVP, Corporate Treasurer) — 8 transactions totaling $510,294
View all SEC Filings for ACCENDRA HEALTH INC/VA/ (ACH).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | Bernocchi Perry A | EVP, Chief Operating Officer | F | Common Stock | 20841 | $2.03 | 321,821.0000 | 76,897,000 | 6.08% | 0.03% |
| March 20, 2026 | Pesicka Edward A | President & CEO | F | Common Stock | 58945 | $2.03 | 1,090,477.0000 | 76,897,000 | 5.13% | 0.08% |
| March 20, 2026 | Leon Jonathan A | EVP & CFO | F | Common Stock | 11286 | $2.03 | 292,303.0000 | 76,897,000 | 3.72% | 0.01% |
| March 20, 2026 | Galloway Heath H | EVP,General Counsel & CorpSecy | F | Common Stock | 9347 | $2.03 | 169,094.0000 | 76,897,000 | 5.24% | 0.01% |
| March 9, 2026 | Bernocchi Perry A | EVP, Chief Operating Officer | A | Common Stock | 108696 | $0.00 | 342,662.0000 | 76,897,000 | 46.46% | 0.14% |
| March 9, 2026 | Leon Jonathan A | EVP & CFO | A | Common Stock | 85067 | $0.00 | 303,589.0000 | 76,897,000 | 38.93% | 0.11% |
| March 9, 2026 | Galloway Heath H | EVP,General Counsel & CorpSecy | A | Common Stock | 61437 | $0.00 | 178,441.0000 | 76,897,000 | 52.51% | 0.08% |
| Nov. 19, 2025 | Long Andrew G | EVP, CEO P&HS | G | Common Stock | 47908 | $0.00 | 448,425.0000 | 77,288,000 | 9.65% | 0.06% |
| Sept. 23, 2025 | Leon Jonathan A | EVP & CFO | F | Common Stock | 4265 | $5.40 | 218,522.0000 | 76,935,000 | 1.91% | 0.01% |
| Aug. 12, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock, par value $2 per share ("Common Stock") | 720000 | $5.15 | 12,282,955.0000 | 76,935,000 | 6.23% | 0.94% |
| Aug. 14, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock | 492852 | $5.31 | 13,100,807.0000 | 76,935,000 | 3.91% | 0.64% |
| Aug. 13, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock | 325000 | $5.46 | 12,607,955.0000 | 76,935,000 | 2.65% | 0.42% |
| June 3, 2025 | Stone Jennifer A | EVP, CHRO | F | Common Stock | 5764 | $6.35 | 110,327.0000 | 77,272,000 | 4.97% | 0.01% |
| May 19, 2025 | Galloway Heath H | EVP,General Counsel & CorpSecy | F | Common Stock | 1768 | $7.38 | 117,044.0000 | 77,272,000 | 1.49% | 0.00% |
| May 15, 2025 | Bernocchi Perry A | EVP, CEO,. Patient Direct | F | Common Stock | 13394 | $7.00 | 233,966.0000 | 77,272,000 | 5.41% | 0.02% |
| May 15, 2025 | Long Andrew G | EVP, CEO P&HS | F | Common Stock | 19081 | $7.00 | 261,972.0000 | 77,272,000 | 6.79% | 0.02% |
| May 15, 2025 | Rollins Carissa | Director | A | Common Stock | 28914 | $0.00 | 53,902.0000 | 77,272,000 | 115.71% | 0.04% |
| May 15, 2025 | Kline Teresa L. | Director | A | Common Stock | 28914 | $0.00 | 54,125.0000 | 77,272,000 | 114.69% | 0.04% |
| May 15, 2025 | Henkel Robert J | Director | A | Common Stock | 28914 | $0.00 | 77,412.0000 | 77,272,000 | 59.62% | 0.04% |
| May 15, 2025 | Gardner-Smith Kenneth | Director | A | Common Stock | 28914 | $0.00 | 54,922.0000 | 77,272,000 | 111.17% | 0.04% |
| May 15, 2025 | Klemash Stephen W | Director | A | Common Stock | 28914 | $0.00 | 59,051.0000 | 77,272,000 | 95.94% | 0.04% |
| May 15, 2025 | Johnson-Mills Rita | Director | A | Common Stock | 28914 | $0.00 | 54,125.0000 | 77,272,000 | 114.69% | 0.04% |
| May 15, 2025 | Bingham Gwendolyn M | Director | A | Phantom Stock | 28914 | $0.00 | 49,412.0000 | 77,272,000 | 141.06% | 0.04% |
| May 15, 2025 | Beck Mark A | Director | A | Common Stock | 28914 | $0.00 | 40,068.0000 | 77,272,000 | 259.23% | 0.04% |
| May 15, 2025 | Sarkar Snehashish | Other | F | Common Stock | 4336 | $7.00 | 108,586.0000 | 77,272,000 | 3.84% | 0.01% |
| May 15, 2025 | Pesicka Edward A | President & CEO | F | Common Stock | 35208 | $7.00 | 1,149,422.0000 | 77,272,000 | 2.97% | 0.05% |
| May 15, 2025 | Lowry Michael Wayne | SVP, Corporate Controller | F | Common Stock | 1533 | $7.00 | 121,921.0000 | 77,272,000 | 1.24% | 0.00% |
| May 15, 2025 | Leon Jonathan A | EVP & CFO | F | Common Stock | 2641 | $7.00 | 222,787.0000 | 77,272,000 | 1.17% | 0.00% |
| May 15, 2025 | Galloway Heath H | EVP,General Counsel & CorpSecy | F | Common Stock | 1315 | $7.00 | 118,772.0000 | 77,272,000 | 1.10% | 0.00% |
| April 10, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock | 80000 | $7.19 | 11,562,955.0000 | 77,272,000 | 0.70% | 0.10% |
| April 8, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock, par value $2 per share ("Common Stock") | 105000 | $7.96 | 11,257,955.0000 | 77,272,000 | 0.94% | 0.14% |
| April 9, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock | 225000 | $7.39 | 11,482,955.0000 | 77,272,000 | 2.00% | 0.29% |
| April 3, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock, par value $2 per share ("Common Stock") | 160000 | $8.53 | 10,784,599.0000 | 77,272,000 | 1.51% | 0.21% |
| April 4, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock | 128356 | $8.14 | 10,912,955.0000 | 77,272,000 | 1.19% | 0.17% |
| April 7, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock | 240000 | $7.84 | 11,152,955.0000 | 77,272,000 | 2.20% | 0.31% |
| March 20, 2025 | Long Andrew G | EVP, CEO P&HS | F | Common Stock | 4578 | $10.09 | 281,053.0000 | 76,741,000 | 1.60% | 0.01% |
| March 20, 2025 | Lowry Michael Wayne | SVP, Corporate Controller | F | Common Stock | 1059 | $10.09 | 123,454.0000 | 76,741,000 | 0.85% | 0.00% |
| March 20, 2025 | Pesicka Edward A | President & CEO | F | Common Stock | 14715 | $10.09 | 1,184,630.0000 | 76,741,000 | 1.23% | 0.02% |
| March 20, 2025 | Sarkar Snehashish | Other | F | Common Stock | 1977 | $10.09 | 112,922.0000 | 76,741,000 | 1.72% | 0.00% |
| March 20, 2025 | Leon Jonathan A | EVP & CFO | F | Common Stock | 1961 | $10.09 | 225,428.0000 | 76,741,000 | 0.86% | 0.00% |
| March 20, 2025 | Bernocchi Perry A | EVP, CEO,. Patient Direct | F | Common Stock | 5551 | $10.09 | 247,360.0000 | 76,741,000 | 2.19% | 0.01% |
| March 20, 2025 | Galloway Heath H | EVP,General Counsel & CorpSecy | F | Common Stock | 2734 | $10.09 | 120,087.0000 | 76,741,000 | 2.23% | 0.00% |
| March 3, 2025 | Lowry Michael Wayne | SVP, Corporate Controller | A | Common Stock | 28166 | $0.00 | 124,513.0000 | 76,741,000 | 29.23% | 0.04% |
| March 3, 2025 | Bernocchi Perry A | EVP, CEO,. Patient Direct | A | Common Stock | 123391 | $0.00 | 252,911.0000 | 76,741,000 | 95.27% | 0.16% |
| March 3, 2025 | Stone Jennifer A | EVP, CHRO | A | Common Stock | 59013 | $0.00 | 116,091.0000 | 76,741,000 | 103.39% | 0.08% |
| March 3, 2025 | Sarkar Snehashish | Other | A | Common Stock | 59013 | $0.00 | 114,899.0000 | 76,741,000 | 105.60% | 0.08% |
| March 3, 2025 | Leon Jonathan A | EVP, Chief Financial Officer | A | Common Stock | 134121 | $0.00 | 285,631.0000 | 76,741,000 | 88.52% | 0.17% |
| March 3, 2025 | Long Andrew G | EVP, CEO P&HS | A | Common Stock | 134121 | $0.00 | 285,631.0000 | 76,741,000 | 88.52% | 0.17% |
| March 3, 2025 | Pesicka Edward A | President & CEO | A | Common Stock | 445279 | $0.00 | 1,199,345.0000 | 76,741,000 | 59.05% | 0.58% |
| March 3, 2025 | Galloway Heath H | EVP,General Counsel & CorpSecy | A | Common Stock | 69743 | $0.00 | 122,821.0000 | 76,741,000 | 131.40% | 0.09% |
| March 3, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock | 354901 | $9.19 | 9,824,599.0000 | 76,741,000 | 3.75% | 0.46% |
| March 4, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock | 800000 | $9.75 | 10,624,599.0000 | 76,741,000 | 8.14% | 1.04% |
| Feb. 28, 2025 | Coliseum Capital Management, LLC | Not found | P | Common Stock, par value $2 per share ("Common Stock") | 1738511 | $9.39 | 9,469,698.0000 | 76,741,000 | 22.49% | 2.27% |
| Nov. 21, 2024 | Leon Jonathan A | EVP, Chief Financial Officer | S | Common Stock | 5282 | $11.82 | 130,822.0000 | 78,476,000 | 3.88% | 0.01% |
| Nov. 15, 2024 | Sarkar Snehashish | Other | F | Common Stock | 1196 | $12.27 | 57,941.0000 | 78,476,000 | 2.02% | 0.00% |
| Nov. 18, 2024 | Sarkar Snehashish | Other | S | Common Stock | 2055 | $12.26 | 55,886.0000 | 78,476,000 | 3.55% | 0.00% |
| Sept. 23, 2024 | Leon Jonathan A | EVP, Chief Financial Officer | A | Common Stock | 42933 | $0.00 | 136,104.0000 | 76,727,000 | 46.08% | 0.06% |
| Aug. 22, 2024 | Leon Jonathan A | SVP, Corp Treasurer, Intm CFO | S | Common Stock | 7500 | $15.83 | 93,171.0000 | 76,727,000 | 7.45% | 0.01% |
| Aug. 8, 2024 | Long Andrew G | EVP, CEO P&HS | G | Common Stock | 70898 | $0.00 | 337,963.0000 | 76,727,000 | 17.34% | 0.09% |
| July 1, 2024 | Lowry Michael Wayne | SVP, Corporate Controller | A | Common Stock | 19202 | $0.00 | 96,347.0000 | 76,727,000 | 24.89% | 0.03% |
| July 1, 2024 | Leon Jonathan A | SVP, Corporate Treasurer | A | Common Stock | 19202 | $0.00 | 100,671.0000 | 76,727,000 | 23.57% | 0.03% |
| June 6, 2024 | Bernocchi Perry A | EVP, CEO,. Patient Direct | S | Common Stock | 1884 | $17.47 | 147,651.0000 | 76,319,000 | 1.26% | 0.00% |
| June 6, 2024 | Bernocchi Perry A | EVP, CEO,. Patient Direct | S | Common Stock | 4542 | $17.49 | 132,353.0000 | 76,319,000 | 3.32% | 0.01% |
| June 6, 2024 | Bernocchi Perry A | EVP, CEO,. Patient Direct | S | Common Stock | 2833 | $17.48 | 129,520.0000 | 76,319,000 | 2.14% | 0.00% |
| June 6, 2024 | Bernocchi Perry A | EVP, CEO,. Patient Direct | S | Common Stock | 10756 | $17.49 | 136,895.0000 | 76,319,000 | 7.28% | 0.01% |
| June 5, 2024 | Beck Mark A | Director | S | Common Stock | 9344 | $17.25 | 11,154.0000 | 76,319,000 | 45.58% | 0.01% |
| June 4, 2024 | Sarkar Snehashish | EVP, Chief Information Officer | S | Common Stock | 9980 | $17.32 | 59,137.0000 | 76,319,000 | 14.44% | 0.01% |
| June 3, 2024 | Stone Jennifer A | EVP, CHRO | A | Common Stock | 57078 | $0.00 | 57,078.0000 | 76,319,000 | 9999.99% | 0.07% |
| June 3, 2024 | Bruni Alexander J | EVP, CFO | S | Common Stock | 10568 | $17.76 | 49,950.0000 | 76,319,000 | 17.46% | 0.01% |
| May 17, 2024 | Galloway Heath H | EVP,General Counsel & CorpSecy | S | Common Stock | 2052 | $19.06 | 54,846.0000 | 76,319,000 | 3.61% | 0.00% |
| May 17, 2024 | Galloway Heath H | EVP,General Counsel & CorpSecy | F | Common Stock | 1768 | $19.11 | 53,078.0000 | 76,319,000 | 3.22% | 0.00% |
| May 16, 2024 | Galloway Heath H | EVP,General Counsel & CorpSecy | S | Common Stock | 2031 | $20.18 | 56,898.0000 | 76,319,000 | 3.45% | 0.00% |
| May 15, 2024 | Pesicka Edward A | President & CEO | F | Common Stock | 45604 | $19.78 | 754,066.0000 | 76,319,000 | 5.70% | 0.06% |
| May 15, 2024 | Sarkar Snehashish | Other | F | Common Stock | 4322 | $19.78 | 69,117.0000 | 76,319,000 | 5.89% | 0.01% |
| May 15, 2024 | Lowry Michael Wayne | SVP, Corporate Controller | F | Common Stock | 2077 | $19.78 | 77,145.0000 | 76,319,000 | 2.62% | 0.00% |
| May 15, 2024 | Long Andrew G | EVP, CEO P&HS | F | Common Stock | 27372 | $19.78 | 222,408.0000 | 76,319,000 | 10.96% | 0.04% |
| May 15, 2024 | Leon Jonathan A | SVP, Corporate Treasurer | F | Common Stock | 3204 | $19.78 | 81,469.0000 | 76,319,000 | 3.78% | 0.00% |
| May 15, 2024 | Bruni Alexander J | EVP, CFO | F | Common Stock | 5290 | $19.78 | 60,518.0000 | 76,319,000 | 8.04% | 0.01% |
| May 15, 2024 | Bernocchi Perry A | EVP, CEO,. Patient Direct | F | Common Stock | 20962 | $19.78 | 149,535.0000 | 76,319,000 | 12.29% | 0.03% |
| May 15, 2024 | Galloway Heath H | EVP,General Counsel & CorpSecy | F | Common Stock | 1752 | $19.78 | 58,929.0000 | 76,319,000 | 2.89% | 0.00% |
| May 15, 2024 | Starck Daniel J | EVP, Business Excellence | F | Common Stock | 9446 | $19.78 | 95,612.0000 | 76,319,000 | 8.99% | 0.01% |
| May 9, 2024 | Klemash Stephen W | Director | A | Common Stock | 11154 | $0.00 | 30,137.0000 | 76,319,000 | 58.76% | 0.01% |
| May 9, 2024 | Rollins Carissa | Director | A | Common Stock | 11154 | $0.00 | 24,988.0000 | 76,319,000 | 80.63% | 0.01% |
| May 9, 2024 | Johnson-Mills Rita | Director | A | Common Stock | 11154 | $0.00 | 25,211.0000 | 76,319,000 | 79.35% | 0.01% |
| May 9, 2024 | Kline Teresa L. | Director | A | Common Stock | 11154 | $0.00 | 25,211.0000 | 76,319,000 | 79.35% | 0.01% |
| May 9, 2024 | Bingham Gwendolyn M | Director | A | Phantom Stock | 11154 | $0.00 | 20,498.0000 | 76,319,000 | 119.37% | 0.01% |
| May 9, 2024 | Beck Mark A | Director | A | Common Stock | 11154 | $0.00 | 20,498.0000 | 76,319,000 | 119.37% | 0.01% |
| May 9, 2024 | Gardner-Smith Kenneth | Director | A | Common Stock | 11154 | $0.00 | 26,008.0000 | 76,319,000 | 75.09% | 0.01% |
| May 9, 2024 | Henkel Robert J | Director | A | Common Stock | 11154 | $0.00 | 48,498.0000 | 76,319,000 | 29.87% | 0.01% |
| May 1, 2024 | Bernocchi Perry A | EVP, CEO,. Patient Direct | S | Common Stock | 3890 | $24.53 | 190,701.0000 | 76,319,000 | 2.00% | 0.01% |
| May 1, 2024 | Bernocchi Perry A | EVP, CEO,. Patient Direct | S | Common Stock | 20204 | $24.27 | 170,497.0000 | 76,319,000 | 10.59% | 0.03% |
| April 22, 2024 | Leon Jonathan A | SVP, Corporate Treasurer | S | Common Stock | 5000 | $24.84 | 84,673.0000 | 76,319,000 | 5.58% | 0.01% |
| March 15, 2024 | Bernocchi Perry A | EVP, CEO,. Patient Direct | F | Common Stock | 14946 | $24.99 | 194,591.0000 | 77,367,000 | 7.13% | 0.02% |
| March 15, 2024 | Leon Jonathan A | SVP, Corporate Treasurer | F | Common Stock | 3086 | $24.99 | 89,673.0000 | 77,367,000 | 3.33% | 0.00% |
| March 15, 2024 | Long Andrew G | EVP, CEO P&HS | F | Common Stock | 22785 | $24.99 | 249,780.0000 | 77,367,000 | 8.36% | 0.03% |
| March 15, 2024 | Lowry Michael Wayne | SVP, Corporate Controller | F | Common Stock | 3086 | $24.99 | 79,222.0000 | 77,367,000 | 3.75% | 0.00% |
| March 15, 2024 | Pesicka Edward A | President & CEO | F | Common Stock | 58126 | $24.99 | 799,670.0000 | 77,367,000 | 6.78% | 0.08% |
| March 1, 2024 | Sarkar Snehashish | Other | A | Common Stock | 14205 | $0.00 | 73,439.0000 | 77,367,000 | 23.98% | 0.02% |
| March 1, 2024 | Pesicka Edward A | President & CEO | A | Common Stock | 148134 | $0.00 | 857,796.0000 | 77,367,000 | 20.87% | 0.19% |
| March 1, 2024 | Leon Jonathan A | SVP, Corporate Treasurer | A | Common Stock | 17046 | $0.00 | 92,759.0000 | 77,367,000 | 22.51% | 0.02% |
| March 1, 2024 | Galloway Heath H | EVP,General Counsel & CorpSecy | A | Common Stock | 24351 | $0.00 | 60,681.0000 | 77,367,000 | 67.03% | 0.03% |
| March 1, 2024 | Long Andrew G | EVP, CEO P&HS | A | Common Stock | 50731 | $0.00 | 272,565.0000 | 77,367,000 | 22.87% | 0.07% |
| March 1, 2024 | Lowry Michael Wayne | SVP, Corporate Controller | A | Common Stock | 10654 | $0.00 | 82,308.0000 | 77,367,000 | 14.87% | 0.01% |
| March 1, 2024 | Bernocchi Perry A | EVP, CEO,. Patient Direct | A | Common Stock | 44643 | $0.00 | 209,537.0000 | 77,367,000 | 27.07% | 0.06% |
| March 1, 2024 | Bruni Alexander J | EVP, CFO | A | Common Stock | 24351 | $0.00 | 65,808.0000 | 77,367,000 | 58.74% | 0.03% |
| March 1, 2024 | Starck Daniel J | EVP, Business Excellence | A | Common Stock | 32975 | $0.00 | 105,058.0000 | 77,367,000 | 45.75% | 0.04% |
| Feb. 27, 2024 | Lowry Michael Wayne | SVP, Corporate Controller | S | Common Stock | 10000 | $25.00 | 71,654.0000 | 77,367,000 | 12.25% | 0.01% |
| Feb. 20, 2024 | Leon Jonathan A | SVP, Corporate Treasurer | S | Common Stock | 5000 | $22.00 | 75,713.0000 | 77,367,000 | 6.19% | 0.01% |
| Feb. 7, 2024 | Galloway Heath H | EVP,General Counsel & CorpSecy | F | Common Stock | 107 | $19.96 | 36,330.0000 | 77,367,000 | 0.29% | 0.00% |
| Feb. 7, 2024 | Galloway Heath H | EVP,General Counsel & CorpSecy | S | Common Stock | 97 | $19.91 | 36,437.0000 | 77,367,000 | 0.27% | 0.00% |
| Jan. 17, 2024 | Leon Jonathan A | SVP, Corporate Treasurer | G | Common Stock | 2500 | $0.00 | 80,713.0000 | 77,367,000 | 3.00% | 0.00% |
| Jan. 17, 2024 | Leon Jonathan A | SVP, Corporate Treasurer | S | Common Stock | 7500 | $18.08 | 83,213.0000 | 77,367,000 | 8.27% | 0.01% |
| Dec. 29, 2023 | Sarkar Snehashish | Other | A | Common Stock | 555 | $16.18 | 59,234.0000 | 76,203,000 | 0.95% | 0.00% |
| Dec. 29, 2023 | Lowry Michael Wayne | SVP, Corporate Controller | A | Common Stock | 555 | $16.18 | 81,654.0000 | 76,203,000 | 0.68% | 0.00% |
| Dec. 29, 2023 | Pesicka Edward A | President & CEO | A | Common Stock | 366 | $16.18 | 709,662.0000 | 76,203,000 | 0.05% | 0.00% |
| Dec. 29, 2023 | Galloway Heath H | EVP,General Counsel & CorpSecy | A | Common Stock | 55 | $16.18 | 36,534.0000 | 76,203,000 | 0.15% | 0.00% |
| Dec. 29, 2023 | Bernocchi Perry A | EVP, CEO,. Patient Direct | A | Common Stock | 547 | $16.18 | 164,894.0000 | 76,203,000 | 0.33% | 0.00% |